ABCB1 and cancer: In patients treated with 5-fluorouracil (5-FU), the ABCB1 transporter was reported to be slightly overexpressed in cancer tissue compared with normal tissue (45), whereas the ABCB1 transporter was significantly overexpressed in patients treated with irinotecan (46).